Home▸Articles▸Narcolepsy Wake-Promoting Agents

Understanding Solriamfetol: Dual Inhibition of Dopamine and Norepinephrine Reuptake

Solriamfetol is a novel wake-promoting agent that works by inhibiting the reuptake of two neurotransmitters, dopamine and norepinephrine.

mysimulator teamUpdated June 2026≈ 3 min read▶ Open the simulation

What Solriamfetol Does

Solriamfetol is a medication designed to combat daytime sleepiness, particularly in conditions like narcolepsy. It functions by inhibiting the reuptake of dopamine and norepinephrine into presynaptic neurons, thereby increasing their availability in the synaptic cleft.

This dual mechanism enhances neurotransmission, leading to increased alertness and wakefulness without causing the side effects associated with stimulants like caffeine or amphetamines.

Mechanism of Action

Solriamfetol works by binding to specific sites on norepinephrine and dopamine transporters, preventing these neurotransmitters from being reabsorbed into the presynaptic neuron. This leads to a higher concentration of these neurotransmitters in the synaptic cleft, which can then interact with postsynaptic receptors more effectively.

This enhanced neurotransmission is thought to improve cognitive function and reduce feelings of drowsiness.

live demo · related simulation● LIVE

Clinical Significance

The dual inhibition of dopamine and norepinephrine reuptake by solriamfetol offers a unique approach in treating narcolepsy. By targeting both neurotransmitters, it can provide more comprehensive relief from symptoms such as excessive daytime sleepiness.

Moreover, this mechanism reduces the risk of cardiovascular side effects often associated with other stimulant medications.

Real-World Applications

Solriamfetol has been approved for use in treating moderate to severe narcolepsy and excessive daytime sleepiness. It is particularly beneficial for patients who do not respond well to other treatments or have a history of cardiovascular issues.

Its effectiveness in improving quality of life and cognitive function makes it an important tool in the management of narcolepsy.

Frequently asked questions

How does solriamfetol differ from traditional stimulants?

Solriamfetol differs from traditional stimulants like caffeine or amphetamines by specifically targeting dopamine and norepinephrine reuptake, which reduces the risk of cardiovascular side effects.

Can solriamfetol be used for other conditions besides narcolepsy?

Solriamfetol is primarily approved for treating narcolepsy. However, ongoing research may explore its potential in managing other sleep disorders or cognitive issues.

What are the side effects of solriamfetol?

Common side effects include nausea, headache, and dizziness. More serious side effects such as hypertension and palpitations can occur but are less frequent.

How does solriamfetol compare to modafinil in treating narcolepsy?

Both solriamfetol and modafinil are wake-promoting agents, but solriamfetol has a unique mechanism of dual inhibition of dopamine and norepinephrine reuptake, which may offer additional benefits for certain patients.

Try it live

Everything above runs in your browser — open Solriamfetol Dopamine-Norepinephrine Reuptake Simulator and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open Solriamfetol Dopamine-Norepinephrine Reuptake Simulator simulation

What did you find?

Add reproduction steps (optional)